Published: 2026-02-11
Regulatory teams and medical device professionals should note the upcoming archiving of information sheets on specimen texts for medicinal product information for paracetamol, acetylsalicylic acid, and NSAIDs by Swissmedic. The change affects the way these analgesic products are documented and presented to the public and healthcare professionals.
What Changed?
The information sheets for medicinal product information of analgesics, specifically paracetamol, acetylsalicylic acid, and NSAIDs, are being archived by Swissmedic.
Background
Swissmedic regularly updates and reviews the documentation and presentation of medicinal products to ensure accuracy and compliance with regulatory requirements.
Who is Affected?
Clinical, quality, and regulatory teams involved in the development, approval, and marketing of analgesic products should be aware of this change.
Actions Required
Affected teams should review and update their internal processes and documentation to reflect the archiving of these information sheets.
FAQ
1. What is the reason for archiving the information sheets?
Swissmedic regularly reviews and updates documentation to ensure accuracy and compliance with regulatory requirements.
2. Who is affected by this change?
Clinical, quality, and regulatory teams involved in the development, approval, and marketing of analgesic products.
Conclusion
The archiving of information sheets on specimen texts for medicinal product information for analgesics by Swissmedic affects regulatory teams and medical device professionals involved in the development and approval of these products. It is essential to review and update internal processes and documentation to reflect this change.
Disclaimer
This information is not intended to provide legal advice. Regulatory teams should consult the official Swissmedic announcement and relevant regulatory guidelines for detailed information.
For full information about the Swissmedic announcement, see the link below.